7204US Cardiolipin-GM (FDA cleared)

Intended Use:

AESKULISA Cardiolipin-GM is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgG and /or IgM antibodies against cardiolipin in human serum.

Recombinant Antigens:

n.a.

Native Antigens:

ß2-Glycoprotein I, Cardiolipin

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 7204US
Description: Cardiolipin-GM (FDA cleared)
Kit Configuration: Single - GM
Cut Off: 15
Range: 0 - 300 U/ml
Standard: Harris / Sapporo (GPL/MPL)
Antibodies: IgG, IgM

Downloads